DNDI-6148 是一种治疗内脏利什曼病的新的临床前候选药物。
| 生物活性 | DNDI-6148 is a novel preclinical candidate for the treatment of visceral leishmaniasis. |
| IC50& Target | |
| 分子量 | |
| Formula | |
| CAS 号 | |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
